59. David Craig, CEO of Sarcomatrix Therapeutics on saving lives!

Today, I'm honored to have David Craig, CEO and founder of Sarcomatrix Therapeutics, joining me. With a steadfast commitment to advancing treatments for muscle-wasting diseases, David’s leadership has been the driving force behind Sarcomatrix’s groundbreaking work.Under his guidance, Sarcomatrix is pioneering novel therapies to promote muscle regeneration, with a vision to transform the lives of those living with muscular dystrophies, sarcopenia, cachexia, and more. Motivated by personal connections to these challenges—his niece Chloe, who tragically passed away at just 30, and his brother-in-law—David’s mission is deeply personal.Armed with a Lean Six Sigma Green Belt and PMP® certification, David combines strategic acumen with operational excellence to bring innovative pharmaceutical solutions from concept to global markets. Join us as we dive into his inspiring and very personal journey, the science driving Sarcomatrix’s breakthroughs, and how a relentless pursuit of patient-centered outcomes is reshaping the future of muscle health.www.linkedin.com/in/david-r-craig/ www.sarcomatrix.com Find me on LinkedIn @ www.linkedin.com/in/krev/www.therevellgroup.com